Abbas Kaja M, Kang Gloria J, Chen Daniel, Werre Stephen R, Marathe Achla
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Department of Population Health Sciences, Virginia Polytechnic Institute and State University (Virginia Tech), Blacksburg, VA, United States of America.
PeerJ. 2018 Jul 13;6:e5171. doi: 10.7717/peerj.5171. eCollection 2018.
The study objective is to analyze influenza vaccination status by demographic factors, perceived vaccine efficacy, social influence, herd immunity, vaccine cost, health insurance status, and barriers to influenza vaccination among adults 18 years and older in the United States.
Influenza vaccination coverage among adults 18 years and older was 41% during 2010-2011 and has increased and plateaued at 43% during 2016-2017. This is below the target of 70% influenza vaccination coverage among adults, which is an objective of the Healthy People 2020 initiative.
We conducted a survey of a nationally representative sample of adults 18 years and older in the United States on factors affecting influenza vaccination. We conducted bivariate analysis using Rao-Scott chi-square test and multivariate analysis using weighted multinomial logistic regression of this survey data to determine the effect of demographics, perceived vaccine efficacy, social influence, herd immunity, vaccine cost, health insurance, and barriers associated with influenza vaccination uptake among adults in the United States.
Influenza vaccination rates are relatively high among adults in older age groups (73.3% among 75 + year old), adults with education levels of bachelor's degree or higher (45.1%), non-Hispanic Whites (41.8%), adults with higher incomes (52.8% among adults with income of over $150,000), partnered adults (43.2%), non-working adults (46.2%), and adults with internet access (39.9%). Influenza vaccine is taken every year by 76% of adults who perceive that the vaccine is very effective, 64.2% of adults who are socially influenced by others, and 41.8% of adults with health insurance, while 72.3% of adults without health insurance never get vaccinated. Facilitators for adults getting vaccinated every year in comparison to only some years include older age, perception of high vaccine effectiveness, higher income and no out-of-pocket payments. Barriers for adults never getting vaccinated in comparison to only some years include lack of health insurance, disliking of shots, perception of low vaccine effectiveness, low perception of risk for influenza infection, and perception of risky side effects.
Influenza vaccination rates among adults in the United States can be improved towards the Healthy People 2020 target of 70% by increasing awareness of the safety, efficacy and need for influenza vaccination, leveraging the practices and principles of commercial and social marketing to improve vaccine trust, confidence and acceptance, and lowering out-of-pocket expenses and covering influenza vaccination costs through health insurance.
本研究旨在分析美国18岁及以上成年人的流感疫苗接种状况,分析内容包括人口统计学因素、感知到的疫苗效力、社会影响、群体免疫、疫苗成本、健康保险状况以及流感疫苗接种的障碍。
2010 - 2011年期间,18岁及以上成年人的流感疫苗接种率为41%,到2016 - 2017年有所上升并稳定在43%。这低于《健康人民2020》倡议设定的成年人流感疫苗接种率达到70%的目标。
我们对美国18岁及以上成年人的全国代表性样本进行了一项关于影响流感疫苗接种因素的调查。我们使用Rao - Scott卡方检验进行双变量分析,并使用该调查数据的加权多项逻辑回归进行多变量分析,以确定人口统计学、感知到的疫苗效力、社会影响、群体免疫、疫苗成本、健康保险以及与美国成年人流感疫苗接种率相关的障碍所产生的影响。
年龄较大的成年人(75岁及以上人群中为73.3%)、拥有学士学位或更高学历的成年人(45.1%)、非西班牙裔白人(41.8%)、收入较高的成年人(收入超过15万美元的成年人中为52.8%)、有伴侣的成年人(43.2%)、无工作的成年人(46.2%)以及有互联网接入的成年人(39.9%)的流感疫苗接种率相对较高。认为疫苗非常有效的成年人中,76%每年接种流感疫苗;受到他人社会影响的成年人中,64.2%每年接种;有健康保险的成年人中,41.8%每年接种,而72.3%没有健康保险的成年人从未接种过疫苗。与仅在某些年份接种疫苗的成年人相比,每年都接种疫苗的成年人的促进因素包括年龄较大、认为疫苗效力高、收入较高且无需自付费用。与仅在某些年份接种疫苗的成年人相比,从未接种过疫苗的成年人的障碍包括缺乏健康保险、不喜欢打针、认为疫苗效力低、对感染流感风险的认知低以及对副作用风险的认知。
通过提高对流感疫苗接种的安全性、效力和必要性的认识,利用商业和社会营销的实践与原则来提高对疫苗的信任、信心和接受度,降低自付费用并通过健康保险覆盖流感疫苗接种成本,可以朝着《健康人民2020》设定的70%的目标提高美国成年人的流感疫苗接种率。